Published in Medicine and Law Weekly, August 4th, 2006
The patents represent several years of research and development focused on bringing to market a non-invasive, commercially viable technology that allows clinicians to monitor absolute levels of oxygen saturation in the brain. The new patents (U.S. Patent 7,047,054 and U.S. Patent 7,072,701) cover aspects of the Fore-Sight patient sensor design and laser safety system, as well as the algorithm...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly